Founder

Kemp Dolliver, CFA

Cherrystone Hill Research

Equity Bottom-Up

<p>Cordlife Group's (CLGL:SP) shareholders voted overwhelmingly in favor of selling the company's holdings of China Cord Blood (CO:US) to Golden Meditech (801:HK) for US$6.40/share (subject to revision in the event of an increased price and/or payment of a special dividend.) &nbsp;The move puts Golden Meditech one step closer to privatizing China Cord Blood, but the special committee of CO's board of directors has yet to make a recommendation to shareholders.</p>

Cordlife Group's (CLGL:SP) shareholders voted overwhelmingly in favor of selling the company's holdings of China Cord Blood (CO:US) to Golden Meditech (801:HK) for US$6.40/share (subject to revision in the event of an increased price and/or payment of a special dividend.) &nbsp;The move puts Golden Meditech one step closer to privatizing China Cord Blood, but the special committee of CO's board of directors has yet to make a recommendation to shareholders.

Zhongyuan Union Cell & Gene Eng Corp (600645 CH)

Nanjing Xinjiekou Department S (600682 CH)

QUICKNOTE: Cordlife Holders Vote in Favor of Golden Meditech Deal

Global Cord Blood

QUICKNOTE: Cordlife Holders Vote in Favor of Golden Meditech Deal